Tower Research Capital LLC (TRC) - CENTURY THERAPEUTICS INC ownership

CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 64 filers reported holding CENTURY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CENTURY THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$43,432
+138.5%
17,032
+291.0%
0.00%
Q1 2024$18,208
+38.8%
4,356
+10.3%
0.00%
Q4 2023$13,114
-76.5%
3,950
-85.8%
0.00%
-100.0%
Q3 2023$55,702
+493.1%
27,851
+837.1%
0.00%
Q2 2023$9,391
+117287.5%
2,972
+34.4%
0.00%
Q1 2023$8
-82.6%
2,212
-75.3%
0.00%
-100.0%
Q4 2022$46
-99.9%
8,952
+115.3%
0.00%
+100.0%
Q3 2022$41,000
+51.9%
4,157
+27.8%
0.00%0.0%
Q2 2022$27,000
+170.0%
3,253
+309.7%
0.00%
Q1 2022$10,000
-79.6%
794
-74.1%
0.00%
-100.0%
Q4 2021$49,000
+226.7%
3,065
+413.4%
0.00%
Q3 2021$15,0005970.00%
Other shareholders
CENTURY THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 702,623$11,144,0002.17%
Casdin Capital, LLC 3,206,380$50,853,0001.43%
Logos Global Management LP 614,095$9,739,0001.00%
Parametrica Management Ltd 28,855$459,0000.46%
DAFNA Capital Management LLC 100,135$1,588,0000.40%
Avidity Partners Management LP 851,522$13,505,0000.29%
Deep Track Capital, LP 250,000$3,965,0000.28%
RA Capital Management 914,094$14,498,0000.26%
HHLR ADVISORS, LTD. 614,095$9,740,0000.15%
Orbimed Advisors 307,047$4,870,0000.06%
View complete list of CENTURY THERAPEUTICS INC shareholders